NCT03600649 2023-11-21Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related SarcomasSalarius Pharmaceuticals, LLCPhase 1 Unknown50 enrolled
NCT05266196 2023-08-01A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577)Salarius Pharmaceuticals, LLCPhase 1/2 Unknown10 enrolled